Tacrolimus Exposure in Kidney Transplantation

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

NCT01064791 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients

NCT03749356 ·Status: COMPLETED ·Phase: PHASE4

Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations

NCT02402140 ·Status: COMPLETED ·Phase: NA

Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

NCT04825262 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

NCT01744470 ·Status: UNKNOWN ·Phase: PHASE4

Genetic Factors on Outcomes of Kidney Transplant Patients With Tacrolimus-based Therapy

NCT03764670 ·Status: COMPLETED

Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression

NCT03800576 ·Status: COMPLETED

Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

NCT02706678 ·Status: COMPLETED ·Phase: PHASE4

The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea

NCT02459977 ·Status: UNKNOWN ·Phase: NA

Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

NCT00204191 ·Status: UNKNOWN ·Phase: PHASE4

Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation

NCT00935298 ·Status: COMPLETED ·Phase: PHASE4

Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.

NCT06147648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

NCT01742624 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

NCT02268201 ·Status: TERMINATED ·Phase: PHASE4

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

NCT03978494 ·Status: WITHDRAWN ·Phase: PHASE1

First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction

NCT02356146 ·Status: UNKNOWN

Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence

NCT06960824 ·Status: NOT_YET_RECRUITING

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379 ·Status: COMPLETED ·Phase: PHASE4

Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation

NCT00777933 ·Status: COMPLETED ·Phase: NA

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

NCT02057484 ·Status: COMPLETED

Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing

NCT00028171 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients

NCT02453867 ·Status: UNKNOWN ·Phase: PHASE4

Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients

NCT02808065 ·Status: UNKNOWN

Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients

NCT03173820 ·Status: UNKNOWN ·Phase: NA

The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation

NCT04360031 ·Status: UNKNOWN